iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

The iShares U.S. Pharmaceuticals ETF (IHE) outperformed the Simplify Health Care ETF (PINK) over the past year, delivering 42.40% returns versus 29.30%. IHE offers lower costs (0.38% expense ratio), higher dividend yield (1.62%), and focuses on established pharmaceutical giants like Eli Lilly and Johnson & Johnson. While PINK provides active management with innovation focus and donates profits to breast cancer research, its higher expense ratio (0.51%) and recent underperformance give IHE the edge for 2026.